MCL-1, an anti-apoptotic protein required for intestinal homeostasis, has been associated with chemoresistance in colorectal cancer. This study provides novel insights into the molecular profile and …
SAN DIEGO — A high-fiber plant-based diet may delay progression of certain precursor conditions to multiple myeloma, according to study results presented at ASH Annual…
This case report provides evidence of clinical benefit from EGFR tyrosine kinase inhibitors in colorectal cancer harboring EGFR kinase domain duplication.
Jointly organized by the EHA and EBMT, the 7th European CAR T-cell Meeting is taking place on February 6-8, 2025, in Strasbourg, France, and online,…
Advanced Cancer Therapies serves as a comprehensive forum to promote research, development and application of advanced cancer therapies. This event promotes education and the exchange…
Alexander Spira, MD, and Julia Lazo, RN, spoke with Melinda Reubens, who was diagnosed with EGFR-mutant NSCLC, and her husband Justin.
During the 66th ASH Annual Meeting and Exposition, the Lymphoma Hub was pleased to speak to Stefano Luminari about the latest updates from the inMIND…
In this Blood Spotlight, Huls et al highlight why small molecule inhibitors of menin are creating excitement in the acute myeloid leukemia (AML) field with
Nivolumab plus chemotherapy demonstrated long-term survival benefits in advanced gastric, GEJ, or esophageal cancer in China.
This narrative review explores the potential of biomarker-directed personalized radiotherapy approaches.
